A case of breast cancer with nipple hemorrhage as the only clinical manifestation

doi:10.3969/j.issn.1009-976X.2022.06.013

Abstract

Abstract: A case of breast cancer with nipple hemorrhage as the only clinical manifestation has been treated. After preoperative mammography, breast ultrasound, duct endoscopy, and MRI examinations, selective duct excision were performed. Frozen suggested breast cancer, and finally successful breast-conserving surgery was performed. For breast cancer with pathologic nipple discharge （PND）, even if breast ultrasound and mammography are negative, ductoscopy and MRI should be continued to avoid missed diagnosis. Breast-conserving surgery is also an option for patients with no nipple-areola complex （NAC） involvement and limited lesions.

Key words: breast cancer, nipple hemorrhage, surgery

摘要： 收治一例以乳头溢血为唯一临床表现的乳腺癌,术前通过完善乳腺X线检查、乳腺超声、乳腺导管内镜及乳腺MRI等检查后,择期行右乳病变乳管切除活检术,术中冰冻病理提示乳腺癌,最终成功行右乳癌保乳术。对于伴有病理性乳头溢液的乳腺癌,即使乳腺超声和乳腺X线摄片检查均为阴性,应继续完善乳管镜和乳腺MRI检查避免漏诊;乳头乳晕复合体无受累及病变范围比较局限的患者,保乳手术也是可选的手术方式。

关键词: 乳腺癌, 乳头溢血, 手术

CLC Number:

R737.9

WANG Yong-nan, YAN shan-shan. A case of breast cancer with nipple hemorrhage as the only clinical manifestation[J]. Lingnan Modern Clinics In Surgery, 2022, 22(06): 592-594.

王永南, 严珊珊. 以乳头溢血为唯一临床表现的乳腺癌一例[J]. 岭南现代临床外科, 2022, 22(06): 592-594.

References

[1] 杨阳,王殊,佟富中,等. 乳腺MRI在病理性乳头溢液诊断中的价值[J]. 中华普通外科杂志, 2021, 36(8): 575-578.
[2] Zhang C, Li J, Jiang H, et al.Use of fiberoductoscopy for the management of pathological nipple discharge: ten years follow up of a single center in China[J]. Gland Surg, 2020, 9(6): 2035-2043.
[3] Wong Chung JE, Jeuriens-van de Ven SA, van Helmond N, et al. Does Nipple Discharge Color Predict (pre-) Malignant Breast Pathology?[J]. Breast J,2016,22(2):202-208.
[4] Clark SE, Agrawal A, Laws S, et al.The investigation and management of unilateral nipple discharge[J]. Ann R Coll Surg Engl,2020,102(5):369-374.
[5] Al Nemer A, Kussaibi H.The accuracy of nipple discharge cytology in detecting breast cancer[J]. Diagnosis (Berl), 2020,8(2):269-273.
[6] Weaver M, Stuckey A.Benign Breast Disorders[J]. Obstet Gynecol Clin North Am,2022,49(1):57-72.
[7] Expert Panel on Breast Imaging: Lee SJ, Trikha S, et al. ACR Appropriateness Criteria? Evaluation of Nipple Discharge[J]. J Am Coll Radiol,2017,14(5S):S138-S153.
[8] Zacharioudakis K, Kontoulis T, Vella JX, et al.Can we see what is invisible? The role of MRI in the evaluation and management of patients with pathological nipple discharge[J]. Breast Cancer Res Treat, 2019,178(1):115-120.
[9] Waaijer L, Simons JM, BorelRinkes IH, et al. Systematic review and meta-analysis of the diagnostic accuracy of ductoscopy in patients with pathological nipple discharge[J]. Br J Surg, 2016,103(6):632-643.
[10] Montroni I, Santini D, Zucchini G, et al.Nipple discharge: is its significance as a risk factor for breast cancer fully understood? Observational study including 915 consecutive patients who underwent selective duct excision[J]. Breast Cancer Res Treat, 2010,123(3):895-900.
[11] Dent BL,Miller JA, Eden DJ, et al.Tumor-to-Nipple distance as a predictor of nipple involvement: expanding the inclusion criteria for Nipple-Sparing mastectomy[J]. Plast Reconstr Surg,2017,140: 1e-8.
[12] 刘丽,池月芮. 早期乳腺癌影像学检查现状与展望[J]. 岭南现代临床外科,2019, 19(5):623-627.
[13] Hill MV, Beeman JL, Jhala K, et al.Relationship of breast MRI to recurrence rates in patients undergoing breast-conservation treatment[J]. Breast Cancer Res Treat, 2017,163(3):615-622.
[14] Chang RY, Cheung PS.Nipple Preservation in Breast Cancer Associated with Nipple Discharge[J]. World J Surg,2017,41(1):176-183.
[15] Lago V, Maisto V, Gimenez-Climent J, et al.Nipple-sparing mastectomy as treatment for patients with ductal carcinoma in situ: A 10-year follow-up study[J]. Breast J,2018,24(3):298-303.